Skip to main content

Table 3 The changes and statistical processing in LH and FSH levels of nadir and other points

From: A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

 

1 mo (nadir)

3 mo

6 mo

12 mo

Statistics

LH

Measurement, mIU/mL

0.285 ± 0.385

0.255 ± 0.306

0.303 ± 0.355

0.453 ± 0.479

There were no significant changes between nadir and other points. ANOVA; p = 0.065

FSH

Measurement, mIU/mL

0.889 ± 1.100

0.993 ± 0.100

1.224 ± 1.135

1.83 ± 1.424

There were significant changes between nadir and 12 mo, 3 mo and 12 mo.Tukey-Kramer methods; p = 0.0006

  1. Abbreviations: LH Luteinizing hormone, FSH Follicle Stimulating Hormone. Values are expressed as mean ± SD